rs369249772
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PM1PM2PP2
The NM_000335.5(SCN5A):c.3032C>T(p.Pro1011Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000273 in 1,613,230 control chromosomes in the GnomAD database, with no homozygous occurrence. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000335.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SCN5A | NM_001099404.2 | c.3032C>T | p.Pro1011Leu | missense_variant | Exon 17 of 28 | ENST00000413689.6 | NP_001092874.1 | |
SCN5A | NM_000335.5 | c.3032C>T | p.Pro1011Leu | missense_variant | Exon 17 of 28 | ENST00000423572.7 | NP_000326.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SCN5A | ENST00000413689.6 | c.3032C>T | p.Pro1011Leu | missense_variant | Exon 17 of 28 | 5 | NM_001099404.2 | ENSP00000410257.1 | ||
SCN5A | ENST00000423572.7 | c.3032C>T | p.Pro1011Leu | missense_variant | Exon 17 of 28 | 1 | NM_000335.5 | ENSP00000398266.2 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152160Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000327 AC: 8AN: 244468Hom.: 0 AF XY: 0.0000225 AC XY: 3AN XY: 133348
GnomAD4 exome AF: 0.0000253 AC: 37AN: 1461070Hom.: 0 Cov.: 36 AF XY: 0.0000289 AC XY: 21AN XY: 726806
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152160Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74334
ClinVar
Submissions by phenotype
not provided Uncertain:2
Identified in an infant with sudden unexplained death, but familial segregation information and additional clinical information was not provided (PMID: 24631775); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 29247119, 24631775) -
This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 1011 of the SCN5A protein (p.Pro1011Leu). This variant is present in population databases (rs369249772, gnomAD 0.01%). This missense change has been observed in individual(s) with sudden unexplained death (PMID: 24631775). ClinVar contains an entry for this variant (Variation ID: 403421). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available". The leucine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Cardiac arrhythmia Uncertain:2
This missense variant replaces proline with leucine at codon 1011 of the SCN5A protein. Computational prediction suggests that this variant may have a deleterious impact on protein structure and function (internally defined REVEL score threshold >= 0.7, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in an infant affected with sudden death (PMID: 24631775, 29247119) and in individuals suspected to be affected with epilepsy (PMID: 31696929). This variant has been identified in 9/275824 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
This missense variant replaces proline with leucine at codon 1011 of the SCN5A protein. Computational prediction suggests that this variant may have a deleterious impact on protein structure and function (internally defined REVEL score threshold >= 0.7, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in an infant affected with sudden death (PMID: 24631775, 29247119) and in individuals suspected to be affected with epilepsy (PMID: 31696929). This variant has been identified in 9/275824 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
not specified Uncertain:1
Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: 1 paper in HGMD, classified as VUS; ExAC: 1/8218 East Asian chromosomes -
Cardiovascular phenotype Uncertain:1
The p.P1011L variant (also known as c.3032C>T), located in coding exon 16 of the SCN5A gene, results from a C to T substitution at nucleotide position 3032. The proline at codon 1011 is replaced by leucine, an amino acid with similar properties. This variant has been detected in a sudden unexplained death cohort, in a control cohort of presumed healthy individuals, and in individuals from an epilepsy cohort; however, details were limited (Wang D et al. Forensic Sci. Int., 2014 Apr;237:90-9; Lin Y et al. Circ Cardiovasc Genet, 2017 Dec;10; Kapplinger JD et al. Circ Cardiovasc Genet, 2015 Aug;8:582-95; Li X et al. Ann Hum Genet. 2020 Mar;84(2):161-168). This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at